Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2023-08-10 Regulatory Filings
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
112年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (美時) providing details about fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. It is a regulatory disclosure of financial data related to intercompany and subsidiary guarantees and loans. The document is short (619 characters) and contains specific financial figures but does not present a full financial report or analysis. It is not an announcement of a report publication but a regulatory financial disclosure. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory financial disclosures that do not fit other specific categories.
2023-08-10 Chinese
112年7月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a revenue summary report for a company named 美時, showing monthly and cumulative net operating revenue figures with percentage changes and explanations. It is a brief financial data summary without detailed financial statements or comprehensive analysis. The document length is only 811 characters, indicating it is a short summary rather than a full report. It does not contain quarterly or annual financial statements, nor does it announce or attach a report. This fits the definition of a Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2023-08-10 Chinese
112年07月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, general managers, and other executives. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. This type of document aligns with the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is substantial and contains detailed insider shareholding data, confirming it is not a brief announcement or a report publication notice.
2023-08-08 Chinese
112年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related information. It focuses on insider share ownership and changes, without financial statements or management discussion. There is no indication of it being a full annual or interim report, earnings release, or other financial report. The content matches the definition of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is 4272 characters, which is sufficient for a detailed insider shareholding report. Therefore, the document is best classified as a Director's Dealing (DIRS) filing.
2023-08-08 Chinese
限制員工權利新股
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the issuance of restricted employee shares (無償配股) by the company 美時. It includes specifics about the issuance purpose, conditions, number of shares, vesting schedules, and related governance approvals. The content focuses on the terms and conditions of a share issuance plan aimed at employees, including regulatory approvals and board resolutions. This is not a full financial report, audit report, or earnings release. It is not a simple announcement of a report publication but a substantive disclosure about a capital change event involving share issuance to employees. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length (5424 characters) and detailed content support this classification with high confidence.
2023-07-27 Chinese
本公司受邀參加國票證券舉辦之法人說明會
Investor Presentation Classification · 90% confidence The document is a short announcement about the company (1795 美時) being invited to participate in an institutional investor presentation organized by 國票證券. It provides details such as the date, time, and location of the event, and mentions that the company will explain its financial and operational status to institutional investors. The document does not contain actual financial statements or detailed financial analysis, but rather serves as a notice of the upcoming investor presentation. The length is only 648 characters, indicating it is a brief announcement rather than a full report. Therefore, according to the classification rules, this document fits best under 'Investor Presentation' (IP) as it relates to a detailed presentation for investors focusing on financials, strategy, and market position, even though the actual presentation content is not included here, the announcement is about the event itself. It is not a report publication announcement (RPA) because it is not announcing the release of a report but the occurrence of a presentation event.
2023-07-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.